Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
The Journal of Biological Chemistry|February 26, 2003
Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8Liqing Yu, Jennifer York, Klaus von Bergmann, et al.Metabolism: Clinical and Experimental|March 26, 2002
Influence of simvastatin, pravastatin, and BM 15.766 on neutral sterols in liver and testis of guinea pigsBernhard Lindenthal, Thomas Bertsch, Klaus Fassbender, et al.Metabolism: Clinical and Experimental|February 8, 2002
Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intakeMarcus J Mussner, Klaus G Parhofer, Klaus Von Bergmann, et al.Archives of Neurology|February 15, 2002
Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brainSandra Locatelli, Dieter Lütjohann, Hartmut H J Schmidt, et al.Metabolism: Clinical and Experimental|March 1, 2005
Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosisJacob J Clarenbach, Bernhard Lindenthal, Maria Theresa Dotti, et al.Journal of Lipid Research|September 16, 2005
Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levelsLily Jakulj, Mieke D Trip, Thomas Sudhop, et al.Neuroscience Letters|May 2, 2002
Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controlsPeter Schönknecht, Dieter Lütjohann, Johannes Pantel, et al.Journal of Lipid Research|June 3, 2005
ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bileSilvia Langheim, Liqing Yu, Klaus von Bergmann, et al.International Journal of Molecular Medicine|April 6, 2006
Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's diseaseHeike Kölsch, Dieter Lütjohann, Frank Jessen, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|March 29, 2006
Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levelsThomas Gerloff, Melanie Schaefer, Jessica Mwinyi, et al.Pageof 7